Related Experiment Video
Updated: May 1, 2026

Microsurgical Venous Pouch Arterial-Bifurcation Aneurysms in the Rabbit Model: Technical Aspects
Published on: May 11, 2011
Aneurysmal rupture in microscopic polyangiitis: a case-based review
Keita Imanishi1,2, Kazuhiro Yasuo3, Yusuke Shirai4
1Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Bunkyo-Ku, Tokyo, Japan. k.imanishi.jl@juntendo.ac.jp.
Abstract:
Microscopic polyangiitis (MPA) affects small and medium vessel, which sometimes leads to arterial aneurysms. In English database, only 15 reports refer to ruptured aneurysms in MPA. We experienced a fatal case with MPA who developed multiple visceral aneurysms, resulting in rupture of the hepatic aneurysm. For the better knowledge of aneurysmal rupture in MPA, we reviewed the feature of 16 cases, including our case. Organ involvement observed was glomerulonephritis 100%, pulmonary involvement 25%, peripheral neuropathy 25%, and purpura 12.5%. Locations of ruptured aneurysms were left gastric artery 31.25%, renal and hepatic artery 18.75% each, intracranial and splenic artery 12.5% each, and gastroepiploic and mesenteric artery 6.25% each. Median time to rupture was 45 days after systemic symptom onset, and 15 days after immunosuppressive treatment induction. Symptoms at rupture were visceral pain 68.75% and hemodynamic instability 62.5%. Pathological findings of ruptured aneurysms were acute vasculitis in 5, no evidence of active inflammation in 3. Causes of death were aneurysmal rupture in 5, treatment complications in 3, and total mortality rate was 50%. In conclusion, the initial presentation of MPA resulting in ruptured aneurysms tends to be renal-limited vasculitis. Aneurysms of abdominal medium-sized arteries tend to rupture, from 4 weeks after systemic symptom onset to 2 weeks after immunosuppressive treatment induction. Most aneurysms are less than 10 mm in diameter, develop asymptomatically in a few days, and are recognized when they rupture. Early induction of immunosuppressive treatment has the potential to shrink aneurysms and prevent rupture.
Insights
Microscopic polyangiitis (MPA) can cause arterial aneurysms, with ruptured aneurysms leading to significant mortality. Early immunosuppressive treatment may prevent these dangerous ruptures.
Area of Science:
- Nephrology
- Rheumatology
- Vascular Surgery
Background:
- Microscopic polyangiitis (MPA) is a small and medium vessel vasculitis that can lead to arterial aneurysms.
- Ruptured aneurysms in MPA are rare, with only 15 reported cases in English literature prior to this study.
- This study investigates a fatal case of MPA with multiple visceral aneurysms and reviews existing literature to understand aneurysmal rupture in MPA.
Purpose of the Study:
- To analyze the clinical features, rupture characteristics, and outcomes of arterial aneurysms in patients with microscopic polyangiitis.
- To identify risk factors and optimal timing for intervention in MPA-associated aneurysms.
Main Methods:
- A comprehensive review of 16 cases of ruptured aneurysms in MPA, including one fatal case experienced by the authors.
- Analysis of organ involvement, aneurysm locations, time to rupture, presenting symptoms, pathological findings, and causes of death.
- Correlation of clinical presentation with pathological findings and treatment outcomes.
Main Results:
- Common organ involvement included glomerulonephritis (100%), pulmonary (25%), and peripheral neuropathy (25%).
- Ruptured aneurysms were most frequently found in the left gastric artery (31.25%), renal and hepatic arteries (18.75% each).
- Rupture occurred median 45 days post-symptom onset and 15 days post-immunosuppressive treatment; mortality rate was 50%.
Conclusions:
- MPA-associated ruptured aneurysms often present initially as renal-limited vasculitis, with abdominal medium-sized arteries being prone to rupture.
- Aneurysms typically develop asymptomatically and rupture within weeks of symptom onset or treatment initiation.
- Early immunosuppressive treatment is crucial for potentially shrinking aneurysms and preventing rupture in MPA patients.
Related Concept Videos
Mechanism of Angiogenesis
Aortic Regurgitation I: Introduction
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies

